TF and neoplasm: Upon administration of tCoa-RGD fusion proteins, macroscopic signs of thrombosis were detected at the skin site of tumors in mice bearing SKOV3 xenografts (Fig. 3B), indicating that tCoa-RGD did mediate a selective blood coagulation in tumor blood vessels, as previously reported by TF fusion proteins1–9.